In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...

Opportunistic salpingectomy, or the removal of fallopian tubes in women already undergoing another abdominal or gynecological ...

Today' contributor Jill Martin, who is in remission from breast cancer, said she needs surgery for complications caused by ...

Jill Martin will be undergoing surgery following complications from her breast cancer treatment. “Just when you think the ...

TAIPEI (Taiwan News) — Kaohsiung Chang Gung Memorial Hospital performed its first ovarian tissue freezing surgery at the end ...

Thousands of women with a cancer-causing genetic mutation are facing an agonising wait for a mastectomy, due to a backlog ...

Ovarian cancer reprograms the omentum to shield hidden tumors. New research suggests total omentectomy may curb recurrence and improve long-term outcomes.

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year ...

"Our research demonstrates the power of GLP-1 therapies to transform health outcomes, with especially promising results for ...

The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple ...

“Today” star Jill Martin is still dealing with health issues stemming from her cancer battle. The 49-year-old journalist ...